How new approaches to patient care can ease NHS pressures
There is no doubt that COVID-19 has changed the world, forever. This is particularly true of the NHS and patient care. Going forward, care...
How NHS funding and finances are changing patient pathways
COVID-19 has been a catalyst for change in NHS finance where a new ‘system-level’ funding arrangement has been introduced in England. This sees providers...
Community pharmacy as the front door
We’re facing a very tough winter. No matter where you are, or what you do, the COVID-19 pandemic is affecting the health of us...
COVID-19 and the counterfeit drug crisis
The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
Implications of early COVID-19 vaccine data
News this week has largely been dominated by talk about a COVID-19 vaccine and finnCap’s Rude Health Life Sciences Sector Report is one of...
Ten top tips for pharma and healthcare to avoid data breaches
Every organisation is a software organisation but for healthcare providers and pharmaceutical organisations, the stakes are high when it comes to data breaches. In...
The importance of security for medical device firms
With news hitting the headlines that global pharmaceutical company Pfizer Inc. has suffered a huge data breach and in light of National Cyber Security...
Project management matters
Rebecca Fox, Head of Membership at the Association for Project Management (APM), looks at how projects and project-related skills have taken on a new...
Challenges in recruiting during the pandemic
Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
Latest articles
NICE recommendation for GSK’s ovarian cancer treatment
National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...
Victims of abuse given code word to ask pharmacists for help
Victims of domestic abuse will be able to access much needed support from thousands of pharmacies across the UK, in a new scheme backed...
Positive trial results for Eli Lilly’s Donanemab in Alzheimer’s
A positive Phase 2 Trial of Eli Lilly’s donanemab, an investigational antibody, has shown significant slowing of decline in a composite measure of cognition...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
NICE recommendation for GSK’s ovarian cancer treatment
National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...